High accuracy of quantitative fluorescence polymerase chain reaction combined with non‑invasive pre‑natal testing for mid‑pregnancy diagnosis of common fetal aneuploidies: A single‑center experience in China

  • Authors:
    • Ping Huo
    • Qiuyan Luo
    • Juan Li
    • Baoquan Jiao
    • Limin Rong
    • Jie Zhang
    • Xiaohua Wu
  • View Affiliations

  • Published online on: May 29, 2019     https://doi.org/10.3892/etm.2019.7625
  • Pages: 711-721
  • Copyright: © Huo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Quantitative fluorescence polymerase chain reaction (QF‑PCR) may be used as a mid‑pregnancy test to confirm the diagnosis of common fetal aneuploidies, but its use is controversial. The present study aimed to determine the value of QF‑PCR for diagnostic confirmation of karyotyping and the impact of parental origin and meiosis stage on the detected aneuploidy. The present prospective cohort study included pregnant women (age, 21‑45 years; gestational age, 17‑25 weeks) who consulted between May 2015 and December 2016. Women were screened and only consecutive high‑risk individuals were included (n=428). QF‑PCR analysis of amniocytes was performed. Karyotype analysis was considered the gold standard. Parental karyotyping was performed if the embryo exhibited any aneuploidy. GeneMapper 3.2 was used for data analysis. There were no false‑negative or false‑positive QF‑PCR results, with 100% concordance with the karyotype. The aneuploidy distribution (n=105) was 68.6% for trisomy 21, 19.0% for trisomy 18, 7.6% for sex chromosome aneuploidy, 3.8% for trisomy 13 and 1.0% for 48,XXX,+18. Regarding trisomy 21, most cases (86.1%) were of maternal origin, 8.3% paternal and 6.5% undefined. Trisomy 18 was 88.2% maternal and 11.8% paternal. Maternal meiosis stage errors in trisomy 21 mainly occurred in meiosis I, while the origin of trisomy 18 exhibited similar proportions between meiosis I and II. The combination of non‑invasive pre‑natal testing and QF‑PCR may become a rapid and effective method for fetal aneuploidy detection. QF‑PCR may provide more genetic information for clinical diagnosis and treatment than karyotyping alone.
View Figures
View References

Related Articles

Journal Cover

July-2019
Volume 18 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Huo P, Luo Q, Li J, Jiao B, Rong L, Zhang J and Wu X: High accuracy of quantitative fluorescence polymerase chain reaction combined with non‑invasive pre‑natal testing for mid‑pregnancy diagnosis of common fetal aneuploidies: A single‑center experience in China. Exp Ther Med 18: 711-721, 2019.
APA
Huo, P., Luo, Q., Li, J., Jiao, B., Rong, L., Zhang, J., & Wu, X. (2019). High accuracy of quantitative fluorescence polymerase chain reaction combined with non‑invasive pre‑natal testing for mid‑pregnancy diagnosis of common fetal aneuploidies: A single‑center experience in China. Experimental and Therapeutic Medicine, 18, 711-721. https://doi.org/10.3892/etm.2019.7625
MLA
Huo, P., Luo, Q., Li, J., Jiao, B., Rong, L., Zhang, J., Wu, X."High accuracy of quantitative fluorescence polymerase chain reaction combined with non‑invasive pre‑natal testing for mid‑pregnancy diagnosis of common fetal aneuploidies: A single‑center experience in China". Experimental and Therapeutic Medicine 18.1 (2019): 711-721.
Chicago
Huo, P., Luo, Q., Li, J., Jiao, B., Rong, L., Zhang, J., Wu, X."High accuracy of quantitative fluorescence polymerase chain reaction combined with non‑invasive pre‑natal testing for mid‑pregnancy diagnosis of common fetal aneuploidies: A single‑center experience in China". Experimental and Therapeutic Medicine 18, no. 1 (2019): 711-721. https://doi.org/10.3892/etm.2019.7625